Move to Reinstate Multiple Sclerosis Drug
Wed, 21 Sep 2005 03:00 AM EST
BLOOMBERG NEWS... Biogen Idec Inc. and the Elan Corporation said that they would seek federal approval to resume sales of the withdrawn Tysabri drug for multiple sclerosis. ...
Related Topics
- Multiple Sclerosis/ms
- Multiple Sclerosis
- Tuberous Sclerosis
- Multiple Myeloma
- Myeloma, Multiple
- Myeloma
- Lichen Sclerosis
- Multiple Chemical Sensitivity
- Tysabri
- Naltrexone
- Drug Safety
- Prescription Drugs
- Interferon Beta-1a Injection (Rebif
- Drug Side Effects
- Twins, Triplets, Multiple Births
- Interferon Beta-1a Injection (Avonex
- Multiple System Atrophy
- Thalidomide
- Drug Abuse
- Drug Information

Not Signed In -


